Association of levels of N-acetyl-beta-glucosaminidase with severity of psychiatric symptoms in panic disorder

Psychiatry Research

Volumn 60, Issue 2-3, 1996, Pages 185-190

  Garvey, Michael J ^a,b   Noyes Jr , Russell ^b  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b UNIVERSITY OF IOWA   (United States)

Author keywords

Anxiety disorder; Mood states; Serotonin

Indexed keywords

N ACETYL BETA GLUCOSAMINIDASE; SEROTONIN;

ADULT; ANXIETY; ARTICLE; DISEASE SEVERITY; FEMALE; HAMILTON SCALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PANIC; PRIORITY JOURNAL; SYMPTOMATOLOGY;

EID: 0029875205     PISSN: 01651781     EISSN: None     Source Type: Journal    
DOI: 10.1016/0165-1781(96)02761-8     Document Type: Article

References (38)

1. Alderman, M.H., Melcher, L., Drayer, D.E. and Reidenberg, M.M. (1983) Increased excretion of N-acetyl-beta-glucosaminidase in essential hypertension and its decline with antihypertensive therapy. N Engl J Med 309, 1213-1217.
2. Åsberg, M., Träskman, L. and Thorén, P. (1976) 5-HIAA in the cerebrospinal fluid - A suicide predictor? Arch Gen Psychiatry 33, 1193-1197.
3. Ballenger, J.C., Burrows, G.D., DuPont, R.L., Jr., Lesser, I.M., Noyes, R., Jr., Pecknold, J.C., Rifkin, A. and Swinson, R.P. (1988) Alprazolam in panic disorder and agoraphobia: results from a multicenter trial. I. Efficacy in short-term treatment. Arch Gen Psychiatry 45, 413-422.
4. Broderick, P. and Lynch, V. (1982) Behavioral and biochemical changes induced by lithium and L-tryptophan in muricidal rats. Neuropharmacology 671, 671-679.
5. Burry, H.C., Dieppe, P.A., Bresnihan, F.B. and Brown, C. (1976) Salicylates and renal function in rheumatoid arthritis. Br Med J 1, 613-615.
6. Coccaro, E.F. (1989) Central serotonin and impulsive aggression. Br J Psychiatry 155, 52-62.
7. Coccaro, E.F., Siever, L.J., Klar, H.M., Maurer, G., Cochrane, K., Cooper T.B., Mohs, R.C. and Davis, K.L. (1989) Serotonergic studies in patients with affective and personality disorders. Correlates with suicidal and impulsive aggressive behavior. Arch Gen Psychiatry 46, 587-599.
8. Copenhaver, J.H., Schalock, R.L. and Carver, M.J. (1978) Effect of serotonin on Y-maze retention and hippocampal protein synthesis in rats. Pharmacol Biochem Behav 8, 263-270.
9. Dubach, A.C. and Schmidt, A. (1979) Diagnostic Significance of Enzymes and Protein in Urine. Hans Huber Publishers, Bern, Stuttgart, Vienna.
10. Garvey, M.J. and Black, D. (1993) An association between the lysosomal enzyme NAG and urinary free cortisol and platelet imipramine binding. J Psychiatr Res 27, 241-245.
11. Garvey, M.J., Furlong, C., Schaffer, C.B. and Adelman, R. (1988) Elevation of the renal enzyme N-acetyl-beta-glucosaminidase in affectively disordered patients. Acta Psychiatr Scand 77, 247-252.
12. Garvey, M.J. and Noel, M. (1992) Association of N-acetyl-beta-glucosaminidase with specific psychiatric symptoms in bipolar patients. Psychiatry Res 47, 129-139.
13. Garvey, M.J. and Noel, M. (1995) Association of NAG levels with specific psychiatric symptoms in unipolar patients. J Psychiatry Neurosci 20, 20-24.
14. Garvey, M.J., Noyes, R.J., Cook, B., Barrickman, L., Noel, M. and Ghosheh, R. (1990) Elevated levels of N-acetyl-beta-glucosaminidase in affective disorders and chemical dependence. J Affect Disord 19, 279-285.
15. Garvey, M.J., Noyes, R.J., Woodman, C. and Laukes, C. (1993) A biological difference between panic disorder and general anxiety disorder. Biol Psychiatry 34, 572-575.
16. Garvey, M.J., Noyes, R.J., Woodman, C. and Laukes, C. (1995) The association of the serotonin metabolite, 5-HIAA, to the lysosomal enzyme N-acetyl-β-glucosaminidase. Neuropsychobiology 32, 75-78.
17. Garvey, M.J., Tuason, V.B., Blomquist, C.H. and Hwang, S. (1982) Use of renal enzymes to evaluate nephrotoxicity in lithium treated patients. Br J Psychiatry 141, 420-422.
18. Hamilton, M. (1959) The assessment of anxiety states by rating. Br J Med Psychol 32, 50-55.
19. Kahn, R.S., Kalus, O., Wetzler, S. and van Praag, H. (1991) The Role of Serotonin in the Regulation of Anxiety. Brunner/Mazel, New York.
20. Kathol, R.G., Noyes, R.J., Lopez, A.L. and Reich, J. (1988) Relationship of urinary free cortisol levels in patients with panic disorder to symptoms of depression and agoraphobia. Psychiatry Res 24, 211-221.
21. Kunin, C.M., Chesney, R.W., Craig, W.A., England, A.C. and DeAngelis, C. (1978) Enzymuria as a marker of renal injury and disease: studies of N-acetyl-beta-glucosaminidase in the general population. Pediatrics 62, 751-760.
22. Mansell, M.A., Jones, N.F., Ziroyannis, P.N. and Marson, W.S. (1978) N-acetyl-beta-glucosaminidase: a new approach to screening hypertensive patients for renal disease. Lancet II, 803-805.
23. Maruhn, D. (1979) Evaluation of urinary enzyme patterns in patients with kidney disease and primary benign hypertension. Curr Prob Clin Biochem 9, 135-149.
24. McNair, D.M., Lorr, M. and Droppleman, L.F. (1972) Profile of Mood States (Manual). Educational and Industrial Testing Service, San Diego.
25. Nordström, P., Samuelsson, M., Åsberg, M., Träskman-Bendz, L., Åberg-Wistedt, Å., Nordin, C. and Bertilsson, L. (1994) CSF 5-HIAA predicts suicide risk after attempted suicide. Suicide Life Threat Behav 24, 1-9.
26. Price, R.G. (1982) Urinary enzymes, nephrotoxicity, and renal disease. Toxicology 23, 99-135.
27. Price, R.G., Dance, N., Richard, B. and Catell, W.R. (1970) The excretion of N-acetyl-beta-glucosaminidase and beta-glactosidase following surgery to the kidney. Clin Chim Acta 27, 65-72.
28. Reglero, A., Carretero, I. and Cabezas, J.A. (1980) Increased serum alpha-L-fuctosidase and beta-N-acetylglucosaminidase activities in diabetic, cirrhotic, and gastric cancer patients. Clin Chim Acta 103, 155-158.
29. Roy, A., Ågren, H., Pickar, D., Linnoila, M., Doran, A.R., Cutler, N.R. and Paul, S.M. (1986) Reduced CSF concentrations of homovanillic acid and homovanillic acid to 5-hydroxyindoleacetic acid ratios in depressed patients: relationship to suicidal behavior and dexamethasone non-suppression. Am J Psychiatry 143, 1539-1545.
30. Sheehan, D. (1986) The Anxiety Disease. Rev. edn. Bantam, New York.
31. Spitzer, R.L. and Williams, B.W. (1982) Structured Clinical Interview for DSM-III. Biometrics Research Department, New York State Psychiatric Institute, New York.
32. Thompson, J.N., Stoolmiller, A.C., Matalion, R. and Darfman, A. (1973) N-acetyl-beta-hexosaminidase: role in degradation of glycosominoglycans. Science 181, 866-867.
33. Tucker, S.M., Boyd, P., Thompson, A.E. and Price, R.G. (1975) Automated assay of N-acetyl-beta-glucosaminidase in a normal pathological human urine. Clin Chim Acta 62, 333-339.
34. Tucker, S.M., Pierce, R.J. and Price, R.G. (1980) Characterization of human N-acetyl-β-glucosaminidase isoenzymes as an indicator of tissue damage in disease. Clin Chim Acta 102, 29-40.
35. Wellwood, J.M., Ellis, B.G., Price, R.G., Hammond, K., Thompson, A.E. and Jones, N.F. (1975) Urinary N-acetyl-beta-D-glucosaminidase activities in patients with renal disease. Br Med J 3, 408-411.
36. Wellwood, J.M., Price, R.G., Ellis, B.G. and Thompson, A.E. (1976) A note on the practical aspects of the N-acetyl-beta-glucosaminidase in human urine. Clin Chim Acta 69, 85-91.
37. Whiting, P.H., Ross, I.S. and Borthwick, L. (1979) Serum and urine N-acetyl-beta-glucosaminidase in diabetics on diagnosis and subsequent treatment, and stable insulin dependent diabetics. Clin Chim Acta 92, 459-463.
38. Wollen, J.W. and Turner, P. (1965) Plasma N-acetyl-beta-glucosaminidase and beta-glucuronidase in health and disease. Clin Chim Acta 12, 671-683.